Last updated 16 days ago

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

1130 patients around the world
Available in Spain, Argentina
Hoffmann-La Roche
9Research sites
1130Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Large B-cell lymphoma
Lymphoma
Non-Hodgkin lymphoma
Requirements for the patient
To 80 Years
All Gender
Medical requirements
Sites
Centro de Internación e Investigación Clínica FUNDALEU
Recruiting
J. E. Uriburu 1450, CABA, Buenos Aires
Sanatorio Allende (Nueva Córdoba)
Recruiting
Hipolito Yrigoyen 384, Córdoba
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Av. Crámer 1180, CABA, Buenos Aires
Centro Médico Austral OMI - CABA
Montevideo 955, C1019ABS Cdad. Autónoma de Buenos Aires, Argentina
Hospital Alemán
Recruiting
Av. Pueyrredón 1640, CABA, Buenos Aires
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Recruiting
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Hospital General de Mexico Dr. Eduardo Liceaga - Ciudad de México
Recruiting
Dr. Balmis 148, Col. Doctores, Del. Cuauhtémoc, Ciudad de México
Instituto Nacional de Cancerología - Ciudad de México
Recruiting
Avenida San Fernando 22, México DF
Health Pharma Professional Research
Recruiting
Dakota 351, Nápoles, Benito Juárez, 03840 Ciudad de México, CDMX, Mexico
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy